Drug Utilization Review (DUR) Program
- DUR Board Meeting Information & Meeting Materials
- DUR Annual Reports
- Intervention Outcomes & Topics
The Omnibus Budget Reconciliation Act of 1990 (OBRA '90) required each state Medicaid Program to establish a Drug Utilization Review (DUR) program for outpatient drugs. The DUR program provides education to physicians, mid-level practitioners and pharmacists. This education is provided through patient profile reviews, population-based interventions, academic detailing visits and a quarterly newsletter.
By Kansas law, the DUR Board is composed of four physicians, four pharmacists and one Advanced Registered Nurse Practitioner (ARNP) or Physician’s Assistant (PA). Each appointment is for three years. The Board is responsible for implementing and operating the DUR Program and making recommendations to DHCF regarding drug therapy issues. The DUR Board meets quarterly, the second Wednesday of the month. All meetings are held in accordance with K.S.A. 75-4319 (Kansas Open Meetings Act).
DUR Program Contacts:
Kelley Melton, Pharm.D.
Division of Health Care Finance
Senior Pharmacy Program Manager
Nicole Ellermeier, Pharm.D.
Health Information Designs
6700 SW Topeka Blvd, Bldg 283
Topeka, KS 66619